v3.25.2
Unaudited Condensed Consolidated Statements of Stockholders' Deficit - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Treasury Stock
Beginning balance (shares) at Dec. 31, 2023   89,595        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Restricted stock units vested (shares)   1,103        
Ending balance (shares) at Jun. 30, 2024   90,698        
Stockholders' deficit, beginning of period at Dec. 31, 2023 $ (39,496) $ 9 $ 167,988 $ (4,167) $ (202,210) $ (1,116)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock based compensation expense     4,963      
Other comprehensive loss       (1,755)    
Net income (loss) 169       169  
Stockholders' deficit, end of period at Jun. 30, 2024 (36,119) $ 9 172,951 (5,922) (202,041) (1,116)
Beginning balance (shares) at Mar. 31, 2024   89,931        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Restricted stock units vested (shares)   767        
Ending balance (shares) at Jun. 30, 2024   90,698        
Stockholders' deficit, beginning of period at Mar. 31, 2024 (36,312) $ 9 170,546 (4,858) (200,893) (1,116)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock based compensation expense     2,405      
Other comprehensive loss       (1,064)    
Net income (loss) (1,148)       (1,148)  
Stockholders' deficit, end of period at Jun. 30, 2024 $ (36,119) $ 9 172,951 (5,922) (202,041) (1,116)
Beginning balance (shares) at Dec. 31, 2024   91,120        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options for cash (shares) 3 3        
Restricted stock units vested (shares)   1,381        
Ending balance (shares) at Jun. 30, 2025   92,504        
Stockholders' deficit, beginning of period at Dec. 31, 2024 $ (69,445) $ 9 177,533 (7,389) (238,482) (1,116)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock based compensation expense     5,575      
Exercise of stock options for cash     9      
Other comprehensive loss       1,218    
Net income (loss) 33,608       33,608  
Stockholders' deficit, end of period at Jun. 30, 2025 (29,035) $ 9 183,117 (6,171) (204,874) (1,116)
Beginning balance (shares) at Mar. 31, 2025   91,351        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options for cash (shares)   1        
Restricted stock units vested (shares)   1,152        
Ending balance (shares) at Jun. 30, 2025   92,504        
Stockholders' deficit, beginning of period at Mar. 31, 2025 (63,696) $ 9 180,241 (7,698) (235,132) (1,116)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock based compensation expense     2,873      
Exercise of stock options for cash     3      
Other comprehensive loss       1,527    
Net income (loss) 30,258       30,258  
Stockholders' deficit, end of period at Jun. 30, 2025 $ (29,035) $ 9 $ 183,117 $ (6,171) $ (204,874) $ (1,116)